Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01942317
Other study ID # 20232
Secondary ID 2023220232
Status Not yet recruiting
Phase N/A
First received September 10, 2013
Last updated September 10, 2013
Start date October 2013
Est. completion date September 2015

Study information

Verified date September 2013
Source University of Padua
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate the role of balneotherapy in obese patients with knee osteoarthritis in terms of pain relief, improving joint function and deambulation, on endocrinological parameters, quality of life and of reduction the costs to "Servizio Sanitario Nazionale" (NHS).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 74
Est. completion date September 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 70 Years
Eligibility Inclusion Criteria:

- obesity II-III grade (BMI 35-45 kg/m2)

- knee pain

- patient compliance to the treatment

Exclusion Criteria:

- BMI<34,9kg/m2 or BMI> 45,1kg/m2

- previous knee surgery

- complicated diabetes mellitus

- ischemic cardiomyopathy and heart failure

- acute phase of osteoarthritis

- varicose veins, deep venous thrombosis (DVT)

- cancer

- cutaneous lesions

- NSAIDs administration <1 week before the treatment

- knee infiltration <2 months before the treatment

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Other:
Balneotherapy


Locations

Country Name City State
Italy Azienda Ospedaliera-Università degli studi di Padova Padua

Sponsors (1)

Lead Sponsor Collaborator
University of Padua

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Knee pain measurement with Visual Analogue Scale (VAS) At the begining and at the end of the treatment. After 6 months of the end of therapy No
Secondary Knee range of motion At the begining and at the end of the treatment. After 6 months of the end of therapy No